IMVT
Immunovant, Inc.
$39.71
-1.38 (-3.36%)
At close · Jul 10
Market Cap
$8.15B
Shares
205,308,917
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$39.71
Open$41.10
Day$39.40–41.10
52W$14.32–41.23
Avg vol 30d1.6M
Short int18.0M · 8.8% float · 8.6d
Short vol81%
Last earningsMay 20, 2026
DataJan 2020–Jul 2026
Filing10-K · May 20
Up next
Next earnings call
Jan 11, 2027
Est · unconfirmed
· in 26 wks
FQ2-27 quarter ends
~Sep 30, 2026
Est
filed May 20, 2026
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+51%
above
Price vs 50-day avg
+20%
above
RSI (14)
66
neutral
MACD trend
Positive
52-week position
94%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+27%
trailing
6-month return
+53%
trailing
YTD return
+56%
this year
Relative strength
+44%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $33 › 200d $26 — 50d above 200d
Institutional flow
Distributing
8 of 216 funds reported for Jun 30 · net -164.4K sh shares
Insider flow
Distributing
Net -$12.4M over 90 days · 100% sells
Short interest
Falling
8.76% of float · ▼ -7.0% MoM · 8.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
216 holders — mid 3-yr range
Squeeze score
81
high risk · 0–100
Fundamentals
EPS growth
−1%
Y/Y
Free cash flow
$-407.3M
Balance sheet
$902.1M
net cash
Quant / Vol
risk profile
Volatility
63%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
3.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+51%
Bullish
Price vs 50-day avg
+20%
Bullish
RSI (14)
66
Neutral
MACD trend
Positive
Bullish
52-week position
94%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $33 › 200d $26 — 50d above 200d
Institutional flow
Distributing
8 of 216 funds reported for Jun 30 · net -164.4K sh shares
Insider flow
Distributing
Net -$12.4M over 90 days · 100% sells
Short interest
Falling
8.76% of float · ▼ -7.0% MoM · 8.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
216 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $14
Now $40 · 94%
52-wk high $41
vs 200-day avg +51%
vs 50-day avg +20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP G&A expenses non-GAAP | $12.4M | three months ended March 31, 2026 | -67.2% |
|
|
|||
| Non-GAAP net loss non-GAAP | $312.9M | nine months ended December 31, 2025 | — |
| Non-GAAP R&D expenses non-GAAP | $290.9M | nine months ended December 31, 2025 | — |
| Shares of common stock issued and outstanding | 203,316,885 | as of December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMVT
this stock
Immunovant, Inc.
|
$8.15B | +56.2% | — | — | 8.8% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMVT | +2.4% | +27.4% | +52.7% | +3.1% | +56.2% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | +1.0% | +23.3% | +43.7% | +2.0% | +45.5% |